Drug
Toremifene clinical trials
Also written Fareston.
- studies test it
- 24
- open now
- 1
- in phase 3
- 13
- first study started
- 1991
Keep track of what changes. Save the Toremifene studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Other names
Combined with it in one product
Studies by the year they started
24 studies that test it; most in 2014 (5)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1993 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 13
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 16
GTx (4) · Intarcia Therapeutics (4) · Peking Union Medical College Hospital (3) · Satakunta Central Hospital (2) · Shanghai Jiao Tong University School of Medicine (1) · Mayo Clinic (1) · Joel Nelson, MD (1) · Advocate Lutheran General Hospital (1)
Often tested with
Tested in the same studies.
Atamestane (4) · Tamoxifen (4) · Anastrozole (4) · Letrozole (3) · Cyclophosphamide (1) · Doxorubicin (1) · Epirubicin (1) · Goserelin (1)
Studies
Open first, then newest update. How each study uses Toremifene is read from its arms, and is right about nine times in ten.
Testing it · 24
- Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast CancerRecruitingPhase 3Chinese Anti-Cancer AssociationNCT03351062Written as Toremifene
- Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)CompletedPhase 3GTxNCT00106691Written as Toremifene 20 mg
- Selective Estrogen Modulation and Melatonin in Early COVID-19WithdrawnPhase 2Reena Mehra, MDNCT04531748Written as Toremifene
- Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast CancerCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT02344940Written as Toremifene
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnPhase 4Fred Hutchinson Cancer CenterNCT03238703Written as Toremifene Citrate
- Toremifene in Treating Patients With Ovarian CancerWithdrawnPhase 2George Washington UniversityNCT00003865Written as toremifene
- Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownPhase 4Peking Union Medical College HospitalNCT02089854Written as Toremifene; Anastrozole
- Estradiol-Receptor Blockade in Older Men and WomenCompletedPhase 1Mayo ClinicNCT02271282Written as Toremifene
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownPhase 3Peking Union Medical College HospitalNCT02097459Written as Toremifene
- Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate CancerCompletedPhase 2Joel Nelson, MDNCT00020735Written as toremifene
- Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerCompletedPhase 3Intarcia TherapeuticsNCT00044291Written as toremifene
- Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular TargetsStatus unknownPhase 2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoNCT02353429Written as Toremifene
- Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced AmenorrhoeaStatus unknownPhase 3Peking Union Medical College HospitalNCT02132390Written as Toremifene
- Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast CancerTerminatedPhase 3Intarcia TherapeuticsNCT00010322Written as toremifene
- Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedPhase 3GTxNCT00129142Written as Toremifene Citrate
- A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)CompletedPhase 2GTxNCT00028353Written as GTX-006 (Acapodene)
- Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate CancerWithdrawnPhase 3GTxNCT01214291Written as Toremifene
- Toremifene in Treating Patients With Desmoid TumorsCompletedPhase 2Advocate Lutheran General HospitalNCT00002595Written as toremifene
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedPhase 3ETOP IBCSG Partners FoundationNCT00002529Written as toremifene
- Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerTerminatedPhase 2Japan Breast Cancer Research NetworkNCT00437359Written as Toremifene citrate
See all 24 studies that test Toremifene →
Given in every arm · 2 — Toremifene is usual care beside what is tested
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)RecruitingPhase 3Fudan UniversityNCT05891093Written as Toremifene
- Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast CancerStatus unknownPhase 2N.N. Petrov National Medical Research Center of OncologyNCT02506790Written as Toremifene
As the comparator · 1 — what is tested is compared with Toremifene
Codes
What other systems call Toremifene · ClinicalTrials.gg INT008580
- MeSH (NLM) D017312ToremifeneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7NFE54O27TTOREMIFENEConfirmed FDA, NLM, Wikidata
- RxNorm 38409Confirmed FDA, Wikidata
- Wikidata Q3993743(Z)-ToremifeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1256ToremifeneOne source FDA
- DrugBank DB00539One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017312 | Toremifene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7NFE54O27T | TOREMIFENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 38409 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3993743 | (Z)-Toremifene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1256 | Toremifene | One source FDA |
| DrugBank | DB00539 | — | One source Wikidata |
Also registered as toremifene citrate (UNII 2498Y783QT · RxNorm 49953).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.